Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether his Department has any plans to move away from a tax-funded NHS towards one funded by insurance and co-payments.
Answered by Philip Dunne
There is no plan to change the way that the National Health Service is funded nor any consideration of changes. The Government remains committed to the principles of the NHS, enshrined in the NHS Constitution, that access to NHS services is based on clinical need, not the ability to pay.
The Government is also committed to working with the NHS in implementing its own plan for the future of the NHS – the Five Year Forward View – backed up by the commitment made in the Spending Review to provide an additional £10 billion in real terms by 2020-21 compared to 2014-15. This fully funds the plan.
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps the Government has taken to evaluate the effectiveness of the 2014 mental health pilots aimed at helping people with mental health problems back into work.
Answered by Alistair Burt
We have published the following evaluation reports of mental health and work pilots:
― Evaluation of the ‘Telephone Support’ Psychological Wellbeing and Research report (September 2015). A copy of the document is available at the following link:
― Evaluation of Group Work Psychological Wellbeing and Work Feasibility (September 2015). A copy of the document is available at the following link:
― Evaluation of the ‘IPS in IAPT’ Psychological Wellbeing and Work Feasibility (March 2015). A copy of the document is available at the following link:
https://www.gov.uk/government/publications/helping-people-with-mental-health-problems-find-work
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much was recharged to the (a) Russian, (b) Chinese, (c) Nigerian, (d) American, (e) Indian, (f) Australian, (g) Pakistan, (h) Brazilian, (i) New Zealand and (j) Canadian government for health treatment by the NHS in 2015.
Answered by Alistair Burt
Anyone who is not ordinarily resident in England is deemed an overseas visitor and is subject to the National Health Service (Charges to Overseas Visitors) Regulations 2015. These regulations place a legal duty on National Health Service hospitals to establish whether an overseas visitor is chargeable or is exempt from charge under one of a number of exemption categories.
NHS trusts will have their own local data on the status of non-United Kingdom nationals receiving NHS care. This enables them to charge for that care where applicable. However, trusts are only obliged to report totals for amounts charged and recovered. They are not required to include information about the patient’s residency, nationality or migration status. Trusts report amounts charged and recovered as part of their own local accounts process.
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, when he last issued guidance to NHS providers on systems for recharging to other countries the cost of NHS treatment of foreign nationals.
Answered by Alistair Burt
An updated version of the ‘guidance on implementing the overseas visitor hospital charging regulations’ was issued to National Health Service bodies on 1 February 2016. This guidance explains what should happen when an overseas visitor, including from the European Economic Area (EEA) needs NHS treatment provided by an NHS hospital in England.
The Department on behalf of the United Kingdom Government reimburses other EEA countries and Switzerland for the cost of providing treatment to people we are responsible for under European Union law, irrespective of nationality. In the same way, other EEA countries and Switzerland reimburse the UK for the cost of the NHS providing treatment to people they are responsible for under EU law, including UK nationals insured in another EEA country or Switzerland.
The table below provides information about how much the UK paid to other EEA countries and Switzerland, and how much was paid to the UK for NHS provided treatments. Visitors from other countries are charged directly for their healthcare.
| |||||
|
| ||||
|
| ||||
| EEA Medical Costs | Member State Claims (against UK) | UK Claims (against EEA, Switzerland) | ||
|
| 2014-15 | 2014-15 |
| |
| Austria | £5,473,017 | £366,756 |
| |
| Belgium | £5,816,026 | £4,323,308 |
| |
| Bulgaria | £255,924 | £363,911 |
| |
| Cyprus | £10,132,385 | £347,045 |
| |
| Czech Republic | £617,758 | £471,140 |
| |
| Denmark (Waiver) | N/A | N/A |
| |
| Estonia (Waiver) | N/A | £154,928 |
| |
| Finland (Waiver) | £10,047 | £243,740 |
| |
| France | £147,685,772 | £6,730,292 |
| |
| Germany | £25,873,954 | £2,189,664 |
| |
| Greece | £2,682,953 | £1,732,047 |
| |
| Hungary (Waiver) | £412 | £22,196 |
| |
| Iceland | £295,943 | £11,331 |
| |
| Ireland | £215,313,962 | £19,214,031 |
| |
| Italy | £7,304,484 | £1,510,850 |
| |
| Latvia | £14,725 | £300,319 |
| |
| Liechtenstein | £193 | £0 |
| |
| Lithuania | £283,625 | £293,616 |
| |
| Luxembourg | £683,410 | £75,151 |
| |
| Malta (Waiver) | N/A | N/A |
| |
| Netherlands | £8,655,688 | £3,251,412 |
| |
| Norway (Waiver) | £30,370 | £0 |
| |
| Poland | £4,336,701 | £1,523,402 |
| |
| Portugal | £6,351,400 | £700,653 |
| |
| Romania | £13,330 | £498,354 |
| |
| Slovakia | £438,715 | £124,348 |
| |
| Slovenia | £266,623 | £107,948 |
| |
| Spain | £223,290,021 | £3,412,338 |
| |
| Sweden | £1,918,038 | £1,367,213 |
| |
| Switzerland | £6,672,560 | £400,131 |
| |
| Total | £674,418,036 | £49,736,125 |
| |
Source: Resource Accounting and Budgeting (RAB) exercise. Totals are based on estimates of the costs of European Economic Area (EEA) healthcare claims made annually for the purposes of provisions made in the Department of Health accounts in accordance with Treasury resource accounting rules.
Notes: Waiver is an agreed intentional relinquishment of healthcare costs between Member States
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much was paid to which countries for overseas health treatment of UK nationals in 2015.
Answered by Alistair Burt
An updated version of the ‘guidance on implementing the overseas visitor hospital charging regulations’ was issued to National Health Service bodies on 1 February 2016. This guidance explains what should happen when an overseas visitor, including from the European Economic Area (EEA) needs NHS treatment provided by an NHS hospital in England.
The Department on behalf of the United Kingdom Government reimburses other EEA countries and Switzerland for the cost of providing treatment to people we are responsible for under European Union law, irrespective of nationality. In the same way, other EEA countries and Switzerland reimburse the UK for the cost of the NHS providing treatment to people they are responsible for under EU law, including UK nationals insured in another EEA country or Switzerland.
The table below provides information about how much the UK paid to other EEA countries and Switzerland, and how much was paid to the UK for NHS provided treatments. Visitors from other countries are charged directly for their healthcare.
| |||||
|
| ||||
|
| ||||
| EEA Medical Costs | Member State Claims (against UK) | UK Claims (against EEA, Switzerland) | ||
|
| 2014-15 | 2014-15 |
| |
| Austria | £5,473,017 | £366,756 |
| |
| Belgium | £5,816,026 | £4,323,308 |
| |
| Bulgaria | £255,924 | £363,911 |
| |
| Cyprus | £10,132,385 | £347,045 |
| |
| Czech Republic | £617,758 | £471,140 |
| |
| Denmark (Waiver) | N/A | N/A |
| |
| Estonia (Waiver) | N/A | £154,928 |
| |
| Finland (Waiver) | £10,047 | £243,740 |
| |
| France | £147,685,772 | £6,730,292 |
| |
| Germany | £25,873,954 | £2,189,664 |
| |
| Greece | £2,682,953 | £1,732,047 |
| |
| Hungary (Waiver) | £412 | £22,196 |
| |
| Iceland | £295,943 | £11,331 |
| |
| Ireland | £215,313,962 | £19,214,031 |
| |
| Italy | £7,304,484 | £1,510,850 |
| |
| Latvia | £14,725 | £300,319 |
| |
| Liechtenstein | £193 | £0 |
| |
| Lithuania | £283,625 | £293,616 |
| |
| Luxembourg | £683,410 | £75,151 |
| |
| Malta (Waiver) | N/A | N/A |
| |
| Netherlands | £8,655,688 | £3,251,412 |
| |
| Norway (Waiver) | £30,370 | £0 |
| |
| Poland | £4,336,701 | £1,523,402 |
| |
| Portugal | £6,351,400 | £700,653 |
| |
| Romania | £13,330 | £498,354 |
| |
| Slovakia | £438,715 | £124,348 |
| |
| Slovenia | £266,623 | £107,948 |
| |
| Spain | £223,290,021 | £3,412,338 |
| |
| Sweden | £1,918,038 | £1,367,213 |
| |
| Switzerland | £6,672,560 | £400,131 |
| |
| Total | £674,418,036 | £49,736,125 |
| |
Source: Resource Accounting and Budgeting (RAB) exercise. Totals are based on estimates of the costs of European Economic Area (EEA) healthcare claims made annually for the purposes of provisions made in the Department of Health accounts in accordance with Treasury resource accounting rules.
Notes: Waiver is an agreed intentional relinquishment of healthcare costs between Member States
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much was recharged to (a) other EU countries and (b) non-EU countries for health treatment by the NHS in 2015.
Answered by Alistair Burt
An updated version of the ‘guidance on implementing the overseas visitor hospital charging regulations’ was issued to National Health Service bodies on 1 February 2016. This guidance explains what should happen when an overseas visitor, including from the European Economic Area (EEA) needs NHS treatment provided by an NHS hospital in England.
The Department on behalf of the United Kingdom Government reimburses other EEA countries and Switzerland for the cost of providing treatment to people we are responsible for under European Union law, irrespective of nationality. In the same way, other EEA countries and Switzerland reimburse the UK for the cost of the NHS providing treatment to people they are responsible for under EU law, including UK nationals insured in another EEA country or Switzerland.
The table below provides information about how much the UK paid to other EEA countries and Switzerland, and how much was paid to the UK for NHS provided treatments. Visitors from other countries are charged directly for their healthcare.
| |||||
|
| ||||
|
| ||||
| EEA Medical Costs | Member State Claims (against UK) | UK Claims (against EEA, Switzerland) | ||
|
| 2014-15 | 2014-15 |
| |
| Austria | £5,473,017 | £366,756 |
| |
| Belgium | £5,816,026 | £4,323,308 |
| |
| Bulgaria | £255,924 | £363,911 |
| |
| Cyprus | £10,132,385 | £347,045 |
| |
| Czech Republic | £617,758 | £471,140 |
| |
| Denmark (Waiver) | N/A | N/A |
| |
| Estonia (Waiver) | N/A | £154,928 |
| |
| Finland (Waiver) | £10,047 | £243,740 |
| |
| France | £147,685,772 | £6,730,292 |
| |
| Germany | £25,873,954 | £2,189,664 |
| |
| Greece | £2,682,953 | £1,732,047 |
| |
| Hungary (Waiver) | £412 | £22,196 |
| |
| Iceland | £295,943 | £11,331 |
| |
| Ireland | £215,313,962 | £19,214,031 |
| |
| Italy | £7,304,484 | £1,510,850 |
| |
| Latvia | £14,725 | £300,319 |
| |
| Liechtenstein | £193 | £0 |
| |
| Lithuania | £283,625 | £293,616 |
| |
| Luxembourg | £683,410 | £75,151 |
| |
| Malta (Waiver) | N/A | N/A |
| |
| Netherlands | £8,655,688 | £3,251,412 |
| |
| Norway (Waiver) | £30,370 | £0 |
| |
| Poland | £4,336,701 | £1,523,402 |
| |
| Portugal | £6,351,400 | £700,653 |
| |
| Romania | £13,330 | £498,354 |
| |
| Slovakia | £438,715 | £124,348 |
| |
| Slovenia | £266,623 | £107,948 |
| |
| Spain | £223,290,021 | £3,412,338 |
| |
| Sweden | £1,918,038 | £1,367,213 |
| |
| Switzerland | £6,672,560 | £400,131 |
| |
| Total | £674,418,036 | £49,736,125 |
| |
Source: Resource Accounting and Budgeting (RAB) exercise. Totals are based on estimates of the costs of European Economic Area (EEA) healthcare claims made annually for the purposes of provisions made in the Department of Health accounts in accordance with Treasury resource accounting rules.
Notes: Waiver is an agreed intentional relinquishment of healthcare costs between Member States
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he has made of the potential contribution of city regions to commissioning and delivering healthcare.
Answered by George Freeman
Devolution of health and social care responsibilities has the potential to further progress local integration going beyond statutory health and care services - leading to better patient experience, improved outcomes and more efficient use of local resource.
Devolution creates opportunity for strategic, innovative commissioning, underpinned by a stronger model of local shared accountability.
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he has made of the effect of changes in funding for community pharmacies on the provision of pharmacy services; and what steps he is taking to ensure that busy community pharmacists are not forced to reduce their services.
Answered by Alistair Burt
Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.
The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.
We are consulting the Pharmaceutical Services Negotiating Committee, other pharmacy bodies and patient and public representatives on our proposals.
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to ensure sufficient provision of neuromuscular and respiratory physiotherapy services for adults and children with neuromuscular conditions in the East Midlands.
Answered by Jane Ellison
NHS England is responsible for commissioning specialised care for people with neuromuscular disorders. However, it commissions physiotherapy only as part of an inpatient episode. All other community and hospital outpatient physiotherapy is commissioned by clinical commissioning groups based on an assessment of local needs.
Since 2015, NHS England has provided specific recurrent investment for three muscular dystrophy care advisor posts across the East Midlands.
Asked by: Lord Mann (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many NHS respiratory physiotherapists work with people with muscle wasting conditions in (a) Nottingham, (b) Nottinghamshire and (c) the East Midlands.
Answered by Alistair Burt
The information requested is not collected centrally.